PureTech Founded Entity Gelesis® Releases Preliminary National Launch Results for Plenity®: Record-Breaking Levels of Prescriptions and Online Traffic New Plenity patient prescriptions increased 3.5-fold within the first three weeks of the national media campaign launch Gelesis has projected $58 mi.
Gelesis (NYSE: GLS), the maker of Plenity, announced preliminary results from its broad awareness media campaign that debuted January 31, 2022. Within the .
Gelesis® Releases Preliminary National Launch Results for Plenity®: Record-Breaking Levels of Prescriptions and Online Traffic | Press Releases leta.lv - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from leta.lv Daily Mail and Mail on Sunday newspapers.